Posted on February 5, 2008 by Debra A. McCurdy

FDA Guidance Agenda

The FDA Center for Drug Evaluation and Research has posted its industry guidance agenda for calendar year 2008. Planned guidance documents address, among many other issues, drug advertising, clinical trial design, drug safety information, and labeling. 
Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/71557
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.